Form 4 Filing for ACADIA PHARMACEUTICALS INC

This filing details transactions by Kihara James, Principal Accounting Officer of ACADIA PHARMACEUTICALS INC. On April 5, 2026, 2010 Restricted Stock Units (RSUs) were acquired, with each RSU representing a contingent right to one share of common stock. These RSUs vest in four equal annual installments starting April 5, 2023. Concurrently, 2010 shares of Common Stock were acquired, with a footnote indicating the price per share is subject to further clarification possibly related to tax withholding. Following this, on April 7, 2026, 1030 shares of Common Stock were sold at a weighted average price of $22.20 (ranging from $22.07 to $22.20). These sales were made to cover withholding taxes and tax-related items associated with the vesting of RSUs, intended to comply with Rule 10b5-1(c)(1)(i)(B). Post-transaction, the number of shares owned is 27865.